Parnaparin sodium

Drug Profile

Parnaparin sodium

Alternative Names: ALFA-LMWH; Fluxum; Minidalton; OP 2123; Tromboparin

Latest Information Update: 16 Oct 2007

Price : $50

At a glance

  • Originator Alfa Wassermann Inc; Opocrin
  • Class Anticoagulants; Low molecular weight heparins; Vascular disorder therapies
  • Mechanism of Action Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Thromboembolism

Most Recent Events

  • 08 Jan 2007 ZLB Behring is now called CSL Behring
  • 01 Apr 2004 Aventis Behring LLC has merged with ZLB Bioplasma to form ZLB Behring
  • 27 Feb 2002 Preregistration for Thromboembolism in South Korea (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top